Fluorescence enzymatic assay for bacterial polyphosphate kinase 1 (PPK1) as a platform for screening antivirulence molecules

Francisca Campos, Javiera A. Álvarez, Javiera Ortiz-Severín, Macarena A. Varas, Carlos F. Lagos, Ricardo Cabrera, Sergio A. Álvarez*, Francisco P. Chávez

*Autor correspondiente de este trabajo

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

6 Citas (Scopus)

Resumen

Inorganic polyphosphate (polyP) and its metabolic enzymes are important in several cellular processes related with virulence and antibiotic susceptibility. Accordingly, bacterial polyP synthesis has been proposed as a good target for designing novel antivirulence molecules as alternative to conventional antibiotics. In most pathogenic bacteria, polyphosphate kinase 1 (PPK1), in charge of polyP synthesis from ATP, is widely conserved. Current colorimetric and radioactive polyP synthesis enzymatic assays are not suitable for high-throughput screening of PPK1 inhibitors. Given the ability of polyP to modify the excitation-emission spectra of DAPI (4ʹ-6-diamidino-2-phenylindole), a fluorescence assay was previously developed by using a purified recombinant PPK1 enzyme from Escherichia coli. In this work we have developed a suitable methodology for high-throughput measurement of E. coli PPK1 activity. This platform can be used for the screening putative antimicrobial molecules for related enteropathogenic bacteria.

Idioma originalInglés
Páginas (desde-hasta)2237-2242
Número de páginas6
PublicaciónInfection and Drug Resistance
Volumen12
DOI
EstadoPublicada - 2019

Nota bibliográfica

Publisher Copyright:
© 2019 Campos et al.

Áreas temáticas de ASJC Scopus

  • Farmacología
  • Enfermedades infecciosas
  • Farmacología (médica)

Huella

Profundice en los temas de investigación de 'Fluorescence enzymatic assay for bacterial polyphosphate kinase 1 (PPK1) as a platform for screening antivirulence molecules'. En conjunto forman una huella única.

Citar esto